University of Alberta
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1908-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ualberta.ca
Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery
Phase 2
Completed
- Conditions
- InflammationCardiac Surgical Procedures
- First Posted Date
- 2006-06-14
- Last Posted Date
- 2007-11-27
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 32
- Registration Number
- NCT00336908
- Locations
- 🇨🇦
Stollery Children's Hospital, Edmonton, Alberta, Canada
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 70
- Registration Number
- NCT00328770
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study
Phase 3
Terminated
- Conditions
- Diabetes Mellitus, Type 2Heart Failure, Congestive
- First Posted Date
- 2006-05-15
- Last Posted Date
- 2008-05-14
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 100
- Registration Number
- NCT00325910
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦Misericordia Hospital, Edmonton, Alberta, Canada
Health and Psychological Outcomes of Lifestyle Versus Traditional Physical Activity
Phase 1
Completed
- Conditions
- Sedentary BehaviourAdherenceTraditional ExerciseLifestyle Exercise
- First Posted Date
- 2006-01-24
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 300
- Registration Number
- NCT00281385
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Health First-Study 2
Phase 2
Completed
- Conditions
- Exercise AdherenceSedentary AdultsLifestyleTraditional
- First Posted Date
- 2006-01-24
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 200
- Registration Number
- NCT00281437
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Increasing Walking Following Cardiac Rehabilitation
Phase 2
Completed
- Conditions
- Cardiac DiseasesWalking
- Interventions
- Device: pedometer
- First Posted Date
- 2006-01-24
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 100
- Registration Number
- NCT00281424
- Locations
- 🇨🇦
Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
Safety and Efficacy Study of Intentional Delivery in Women With Preterm and Prelabour Rupture of the Membranes
Not Applicable
Terminated
- Conditions
- Fetal Membranes, Premature Rupture
- Interventions
- Procedure: Induction of delivery
- First Posted Date
- 2005-11-29
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 152
- Registration Number
- NCT00259519
- Locations
- 🇨🇦
St. Boniface General Hospital, Winnipeg, Manitoba, Canada
🇨🇦Women's Hospital, Winnipeg, Manitoba, Canada
🇨🇦Grey Nuns Community Hospital, Edmonton, Alberta, Canada
Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer
Phase 2
Completed
- Conditions
- Head and Neck Neoplasms
- Interventions
- Behavioral: Exercise
- First Posted Date
- 2005-11-03
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 64
- Registration Number
- NCT00248235
- Locations
- 🇨🇦
Behavioral Medicine Laboratory, University of Alberta, Edmonton, Alberta, Canada
Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting
Phase 2
Completed
- Conditions
- Cardiopulmonary BypassReperfusion InjuryCoronary Artery Bypass Grafting
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2017-12-15
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 56
- Registration Number
- NCT00246740
- Locations
- 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
Phase 2
Completed
- Conditions
- Refractory AscitesType 2 Hepatorenal Syndrome
- Interventions
- Drug: midodrine, octreotide, albumin
- First Posted Date
- 2005-10-17
- Last Posted Date
- 2007-12-06
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 9
- Registration Number
- NCT00240045
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath